5459|1546|Public
5|$|Because {{molecular}} diagnostics {{methods can}} detect sensitive markers, these tests are less intrusive than a traditional biopsy. For example, because cell-free nucleic acids exist in <b>human</b> <b>plasma,</b> a simple blood sample can {{be enough to}} sample genetic information from tumours, transplants or an unborn fetus. Many, but not all, molecular diagnostics methods based on nucleic acids detection use polymerase chain reaction (PCR) to vastly {{increase the number of}} nucleic acid molecules, thereby amplifying the target sequence(s) in the patient sample. The detection of the marker might use real time PCR, direct sequencing, or microarray chipsprefabricated chips that test many markers at once. The same principle applies to the proteome and the genome. High-throughput protein arrays can use complementary DNA or antibodies to bind and hence can detect many different proteins in parallel.|$|E
25|$|The normal {{concentration}} of renin in adult <b>human</b> <b>plasma</b> is 1.98–24.6ng/L in the upright position.|$|E
25|$|Distribution: Duloxetine {{is highly}} bound (>90%) to {{proteins}} in <b>human</b> <b>plasma,</b> binding primarily to albumin and α1-acid glycoprotein. Volume of distribution is 1640L.|$|E
50|$|Hydroxyurea {{has been}} {{reported}} as endogenous in <b>human</b> blood <b>plasma</b> at concentrations of approximately 30 to 200 ng/ml.|$|R
50|$|Kallikreins are a {{subgroup}} of serine proteases, enzymes capable of cleaving peptide bonds in proteins. In <b>humans,</b> <b>plasma</b> kallikrein (KLKB1) has no known paralogue, while tissue kallikrein-related peptidases (KLKs) encode {{a family of}} fifteen closely related serine proteases. These genes are localised to chromosome 19q13, forming the largest contiguous cluster of proteases within the human genome. Kallikreins {{are responsible for the}} coordination of various physiological functions including blood pressure, semen liquefaction and skin desquamation.|$|R
40|$|This study {{investigates the}} role of buffalo {{colostrum}} and milk whey derived peptides in protection against oxidative damage induced by 2 4 -Dinitrophenol 2 4 -DNP in human blood serum samples in vitro. A biomarker enzymes for oxidative stress like Alkaline phosphatase ALP and acid phosphatase ACP oxidative damage markers indicating extent of host antioxidant reserve indicators like reduced glutathione GSH were measured by spectrophotometric techniques in four different groups namely 1 <b>Human</b> blood <b>plasma</b> only control 2 <b>Human</b> blood <b>plasma</b> 24 -DNP 3 <b>Human</b> blood <b>plasma</b> colostrum whey derived peptides 24 -DNP 4 <b>Human</b> blood <b>plasma</b> colostrum whey derived peptides 5 <b>Human</b> blood <b>plasma</b> milk whey derived peptides 24 -DNP and 6 <b>Human</b> blood <b>plasma</b> milk whey derived peptides. Following exposure to 2 4 -DNP levels of antioxidants like GSH was significantly decreased in comparison to control e. g. GSH 0. 568 0. 015 vs 0. 871 0. 022 mol 0. 1 mg proteins. In addition the concentration of biomarker enzymes for 24 -DNP induced membrane damage and oxidative stress like ALP and ACP were increased in serum by oxidant compared to control e. g. ALP 5. 497 0. 185 vs. 2. 782 0. 000 molmg protein ACP 1. 689 0. 047 vs. 0. 629 0. 047 molmg protein. Pretreatment with buffalo whey derived peptides significantly protects 24 -DNP induced RBC membrane lyses and release of ALP and ACP into serum environment. e. g. ALP 3. 444 0. 094 vs. 5. 497 0. 185 molmg protein ACP 0. 629 0. 047 vs. 1. 689 0. 047 molmg protein. Pretreatment with whey derived peptides give protection to oxidative damage and shifts the trend towards amelioration and replenishment of the antioxidant status...|$|R
25|$|Valverde was not {{initially}} linked in the investigation, but documents from Madrid's Court 31 linked Valverde {{to a single}} bag of <b>human</b> <b>plasma</b> of the 211 total bags of blood and plasma seized in the investigation. The bag of <b>human</b> <b>plasma</b> was labelled with the codes Valv, Piti and 18. In 2007 Valverde was banned by the International Cycling Union (UCI) from competing in the UCI Road World Championships in Stuttgart but Valverde was cleared by the Court of Arbitration for Sport to compete at the championships. Dick Pound, World Anti-Doping Agency president, said the CAS decision {{did not mean that}} Valverde was no longer a suspect.|$|E
25|$|The most {{sensitive}} method of detecting and measuring EDTA in biological samples is selected-reaction-monitoring capillary-electrophoresis mass-spectrometry (abbreviation SRM-CE/MS), {{which has a}} detection limit of 7.3ng/mL in <b>human</b> <b>plasma</b> and a quantitation limit of 15ng/mL. This method works with sample volumes as small as ~7–8 nL.|$|E
25|$|Haloperidol {{is heavily}} protein bound in <b>human</b> <b>plasma,</b> {{with a free}} {{fraction}} of only 7.5 to 11.6%. It is also extensively metabolized in the liver with only about 1% of the administered dose excreted unchanged in the urine. The greatest proportion of the hepatic clearance is by glucuronidation, followed by reduction and CYP-mediated oxidation, primarily by CYP3A4.|$|E
40|$|Background. Rodent models {{suggest that}} follistatin-like 3 (fstl 3) is {{associated}} with diabetes and obesity. In <b>humans,</b> <b>plasma</b> fstl 3 is reduced with gestational diabetes. In vitro, TNF-α induces fstl 3 secretion, which suggests a link to inflammation. Objective. To elucidate the association between plasma fstl 3 and obesity, insulin resistance, and low-grade inflammation in <b>humans.</b> Study Design. <b>Plasma</b> fstl 3 levels were determined in a cross-sectional study including three groups: patients with type 2 diabetes, impaired glucose tolerance, and healthy controls. In addition, lipopolysaccharide (LPS), TNF-α, or interleukin- 6 (IL- 6) {{as well as a}} hyperinsulinemic euglycemic clamp were used to examine if plasma fstl 3 was acutely regulated in <b>humans.</b> Results. <b>Plasma</b> fstl 3 was increased in obese subjects independent of glycemic state. Moreover, plasma fstl 3 was positively correlated with fat mass, plasma leptin, fasting insulin, and HOMA B and negatively with HOMA S. Furthermore plasma fstl 3 correlated positively with plasma TNF-α and IL- 6 levels. Infusion of LPS and TNF-α, but not IL- 6 and insulin, increased plasma fstl 3 in <b>humans.</b> Conclusion. <b>Plasma</b> fstl 3 is increased in obese subjects and associated with fat mass and low-grade inflammation. Furthermore, TNF-α increased plasma fstl 3, suggesting that TNF-α is one of the inflammatory drivers of increased systemic levels of fstl 3...|$|R
40|$|AbstractMembrane-bound human liver {{alkaline}} phosphatase solubilized by a non-ionic detergent, Nonidet P- 40 (NP- 40), has the molecular mass of a tetramer. It {{can be converted}} to a dimeric form by treatment with a phosphatidylinositol phospholipase C (PI-PLC) obtained from Bacilluscereus. When <b>human</b> liver <b>plasma</b> membranes were directly treated with PI-PLC, the released {{alkaline phosphatase}} was dimeric. Thus, phosphatidylinositol may help maintain the tetrameric quaternary structure of alkaline phosphatase and aid its binding to <b>human</b> liver <b>plasma</b> membranes...|$|R
40|$|The {{ability of}} various human and ovine blood plasmas to inhibit {{prostaglandin}} synthesis in vitro has been tested. <b>Human</b> <b>plasmas</b> {{were significantly more}} potent {{in their ability to}} inhibit prostaglandin synthesis than their counterpart ovine plasmas. In general, female plasma had greater inhibitory activities than male plasmas and adult plasmas were more active than fetal plasmas. There was no simple correlation between the activity of plasmas as inhibitors of prostaglandin synthesis and their respective albumin or haptoglobin contents...|$|R
25|$|Alkyl {{substitution}} {{at position}} 7 has shown increased cytotoxicity, such as ethyl (C2H5) or chloromethyl (CH2Cl). These groups {{are able to}} react with the DNA {{in the presence of}} topo I which leads to more tumor activity. It has also been shown that increasing the length of the carbon chain (in position 7) leads to increased lipophilicity and consequently greater potency and stability in <b>human</b> <b>plasma.</b>|$|E
25|$|IGFBP-3 {{was first}} isolated, characterized, and quantitated in <b>human</b> <b>plasma,</b> in 1986. It has {{well-documented}} {{functions in the}} circulation, in the extracellular environment, and inside cells. It is the main IGF transport protein in the bloodstream, where it carries the growth factors predominantly in stable complexes that contain the binding protein, either IGF-1 or IGF-2, and a third protein called the acid-labile subunit or ALS.|$|E
25|$|Treatment {{includes}} {{the use of}} iron chelating agents (such as desferrioxamine) to lower serum ferritin concentration, brain and liver iron stores, and to prevent progression of neurologic symptoms. This, combined with fresh-frozen <b>human</b> <b>plasma</b> (FFP) effectively in decreasing liver iron content. Repetitive use of FFP can even improve neurologic symptoms. Antioxidants such as vitamin E can be used simultaneously to prevent tissue damage to the liver and pancreas.|$|E
40|$|The {{authors found}} that DOPA/ 5 -HTP decar-boxylase was present In the <b>human</b> seminal <b>plasma</b> and that Its {{activity}} was lower in fertile men than in Infertile men. The Km and Vmax of the enzyme were, respectIvely, 0. 88 x l 06 u and 19. 8 pmol of serotonln/mg of protein/mm. The enzyme was pyridoxal- 5 ’-phosphate (PLP) -independent, {{and the content}} of PLP in the seminal plasma was lower In fertile than in infertile subjects. A soluble, heat stable, dif-fusible Inhibitor of DOPA/ 5 -HTP decarboxylase was detected in seminal plasma. This naturally occurring inhibitor was capable of reducing the activity of decarboxylase in the <b>human</b> seminal <b>plasma</b> and in cat liver. Zinc inhibited DOPAI 5 -HTP decarboxylase in both <b>human</b> seminal <b>plasma</b> and cat liver, suggesting the involve-ment of zinc, in close relationship with PLP, in the decarboxylatlon mechanism. These find-ings suggest a relationship between the syn-thesis of biogenic amines and testicular func-tion in Infertile men. Key words: DOPA/ 5 -HTP decarboxylase, <b>human</b> seminal <b>plasma,</b> biogenic amlnes. DOPA/ 5 -HTP decarboxylase (EC 4. 1. 1. 28), the aromatic a-L-amino acid decarboxylase (Loven...|$|R
25|$|The normal {{antithrombin}} {{concentration in}} <b>human</b> blood <b>plasma</b> is high at approximately 0.12mg/ml, which {{is equivalent to}} a molar concentration of 2.3 μM.|$|R
40|$|Acetaldehyde {{may be the}} {{injurious}} {{agent in}} acute alcoholic liver disease. It {{has been suggested that}} the mechanism of liver injury in this situation may be immunologically mediated. In the present study acetaldehyde has been bound to <b>human</b> liver <b>plasma</b> membranes. The activation of C 3 by the acetaldehyde/membrane product was measured by immunofixation of the separated C 3 components. Activation of C 3 by acetaldehyde exposed liver plasma membranes was increased to 16. 4 % compared with 6 % by non-exposed membranes (p = 0. 004). <b>Human</b> liver <b>plasma</b> membranes bound 212 +/- 18 nmol acetaldehyde per mg membrane protein. The binding constant was 439 +/- 81 microM. It is concluded that acetaldehyde bound to <b>human</b> liver <b>plasma</b> membranes activates the complement sequence and this may be the initial stage in the pathogenesis of acute alcoholic liver disease...|$|R
25|$|Alejandro Valverde {{has been}} linked by {{documentary}} and DNA evidence to the Operación Puerto, a blood-doping affair which erupted in May 2006 against doctor Eufemiano Fuentes {{and a number of}} accomplices. It uncovered doping products, bags of blood and <b>human</b> <b>plasma,</b> and code names that appeared to link top athletes, including up to 60 cyclists, to a highly organized system of doping, which relied heavily on blood transfusions.|$|E
25|$|T. b. rhodesiense is {{the acute}} {{form of the}} disease and death can occur within months since the {{symptoms}} emerge within weeks and it is more virulent and faster developing than T. b. gambiense. Furthermore, trypanosomes are surrounded by a coat that is composed of variant surface glycoproteins (VSG). These proteins act to protect the parasite from any lytic factors that are present in <b>human</b> <b>plasma.</b> The host's immune system recognizes the glycoproteins present on the coat of the parasite leading to the production of different antibodies (IgM and IgG).|$|E
25|$|Another {{possible}} modification is {{to insert}} a methylene between hydroxyl and lactone on the E-ring yielding a seven membered β-hydroxylactone group, so-called homocamptothecin (hCPT). The hCPT’s hydroxyl has less inductive {{effect on the}} carboxyl group which makes the lactone very reactive. This enhances {{the interaction of the}} free hydroxyl group optimally with topo I and the covalent complex that forms in its presence are more stable. The E-ring of hCPT opens more slowly and the opening is irreversible. hCPTs exhibit enhanced <b>human</b> <b>plasma</b> stability because of decreased protein binding and more affinity for red blood cells than CPT.|$|E
5000|$|Mary Price, {{teacher at}} Bromley St Leonard's church school; mother of Professor Ralph Kekwick FRS (1908-2000), {{biochemist}} who did pioneering work on <b>human</b> blood <b>plasma</b> ...|$|R
40|$|F(ab*) 2 {{fragments}} {{are sometimes}} preferred to whole IgG for therapeutic or diagnostic uses. Preclinical pharmaceutical devel-opment studies are necessary before {{their use in}} humans. Here we propose an allometric approach among three mammalian species to predict F(ab*) 2 pharmacokinetic parameters in <b>humans.</b> <b>Plasma</b> disposition of horse antivenom F(ab*) 2 fragments labeled with iodine 125 was studied at a dose of 10 mg/kg iv in mice, rats, and rabbits. Using the allometric method, we demonstrate that the pharmacokinetic parameters that correlated with body weight were distribution volume (Vdc (ml) 5 0. 125...|$|R
40|$|AbstractLysophosphatidic acid (LPA) is a lipid {{mediator}} with multiple biological activities and is detected in various biological fluids, including <b>human</b> seminal <b>plasma.</b> Due to its cell proliferation stimulatory and anti-apoptotic activities, LPA has {{been implicated in}} the progression of some cancers such as ovarian cancer and prostate cancer. Here, we show that prostatic acid phosphatase, which is a non-specific phosphatase and which has been implicated in the progression of prostate cancer, inactivates LPA in <b>human</b> seminal <b>plasma.</b> <b>Human</b> seminal <b>plasma</b> contains both an LPA-synthetic enzyme, lysoPLD, which converts lysophospholipids to LPA and is responsible for LPA production in serum, and its major substrate, lysophosphatidylcholine. In serum, LPA accumulated during incubation at 37 °C. However, in seminal plasma, LPA did not accumulate. This discrepancy is explained {{by the presence of}} a strong LPA-degrading activity. Incubation of LPA with seminal plasma resulted in the disappearance of LPA and an accompanying accumulation of monoglyceride showing that LPA is degraded by phosphatase activity present in the seminal plasma. When seminal plasma was incubated {{in the presence of a}} phosphatase inhibitor, sodium orthovanadate, LPA accumulated, indicating that LPA is produced and degraded in the fluid. Biochemical characterization of the LPA-phosphatase activity identified two phosphatase activities in <b>human</b> seminal <b>plasma.</b> By Western blotting analysis in combination with several column chromatographies, the major activity was revealed to be identical to prostatic acid phosphatase. The present study demonstrates active LPA metabolism in seminal plasma and indicates the possible role of LPA signaling in male sexual organs including prostate cancer...|$|R
25|$|From Unigene's EST cDNA Tissue Abundance {{display and}} Protein Atlas, CXorf66 has a {{moderately}} high expression levels in testes, {{in addition to}} higher expression levels in fetus tissue in comparison to other developmental stages. CXorf66 protein also has a notable low presence in both the control endometrium total RNA and endometriosis total RNA. CXorf66 has been portrayed to have notable presence in the plasma and platelet. Based upon PaxDb data, CXorf66 has been found ranking in the top 5% for one study of <b>human</b> <b>plasma</b> and in the top 25% for another study conducted with human platelet. In addition to this, {{there has been a}} noticeable 60–100% CXorf66 protein presence in both non-failing and dilated cardiomyopathy septum tissue. Furthermore, CXorf66 has a ~75% protein presence in peripheral blood mononuclear cells.|$|E
25|$|Isotretinoin is {{primarily}} (99.9%) bound to plasma proteins, mostly albumin. Three metabolites of Isotretinoin are detectable in <b>human</b> <b>plasma</b> after oral administration: 4-oxo-isotretinoin, retinoid acid (tretinoin), and 4-oxo-retinoic acid (4-oxo-tretinoin). Isotretinoin also oxidizes, irreversibly, to 4-oxo-isotretinoin—which forms its geometric isomer 4-oxo-tretinoin. After an orally-administered, 80mg dose of liquid suspension 14C-isotretinoin, 14C-activity in blood declines with a half-life of 90 hours. The metabolites of isotretinoin and its conjugates are then excreted in the subject's urine and faeces in relatively equal amounts. After a single, 80mg oral dose of Isotretinoin to 74 healthy adult subjects under fed conditions, the mean ±SD elimination half-life (t1/2) of isotretinoin and 4-oxo-isotretinoin were 21.0 ± 8.2 hours and 24.0 ± 5.3 hours, respectively. After both single and multiple doses, the observed accumulation ratios of isotretinoin ranged from 0.90 to 5.43 {{in patients with}} cystic acne.|$|E
25|$|Lp(a) is {{assembled}} at the hepatocyte {{cell membrane}} surface, while other scenarios exist {{with regard to}} the location of assembly. It mainly exists in plasma. Lp(a) contributes to the process of atherogenesis. Because of its structural similarity to plasminogen and tissue plasminogen activator, competitive inhibition leads to reduced fibrinolysis, {{and as a result of}} the stimulation of secretion of plasminogen activator inhibitor 1, Lp(a) leads to thrombogenesis. It may also enhance coagulation by inhibiting the function of tissue factor pathway inhibitor. Lp(a) carries cholesterol and binds atherogenic proinflammatory oxidized phospholipids as a preferential carrier of oxidized phospholipids in <b>human</b> <b>plasma,</b> which attract inflammatory cells to vessel walls and leads to smooth muscle cell proliferation. Moreover, Lp(a) is also hypothesized to be involved in wound healing and tissue repair, interacting with components of the vascular wall and extra cellular matrix. Apo(a), a distinct feature of the Lp(a) particle, binds to immobilized fibronectin and endows Lp(a) with the serine-proteinase-type proteolytic activity.|$|E
5000|$|Şeren, G., Kaplan, M., ibar, H., [...] "A {{comparative}} study of <b>human</b> seminal <b>plasma</b> and blood serum trace elements in fertile and infertile men"; Analytical Letters, 35(11), 1785-1794 (2002) ...|$|R
40|$|Nitric oxide is a {{chemical}} messenger which {{functions as a}} neurotransmitter or as a cytotoxic agent. Nitric oxide synthase (NOS) has been isolated from various mammalian reproductive tissues* The {{presence or absence of}} NOS in spermatozoa has not yet been reported. We therefore tested human and marine spermatozoa for NOS activity by measuring the conversion of argmine to citmlline. No activity was found either in human or in murine spermatozoa. Human native semen and <b>human</b> seminal <b>plasma</b> exerted an inhibition on brain NOS activity, as assayed on rat brain cytosolic fractions. This inhibitory effect was dependent on the amount of protein present in the <b>human</b> seminal <b>plasma.</b> No inhibitory effect was observed when homogenates of washed spermatozoa were tested. The <b>human</b> seminal <b>plasma</b> did not affect the Michaelis constant (Km) of NOS for L-arginine (endogenous NOS substrate) whereas the maximal velocity (Vmax) was reduced, suggesting that it contains a non-competitive inhibitor of brain NOS. This inhibitory component was virtually insensitive to heat; a 10 min treatment to 95 °C only slightly reduced its ability to inhibit brain NOS. The physiological relevance of our observations remains to be elucidated. <b>Human</b> seminal <b>plasma</b> may exert an inhibition of nitric oxide synthesis on cells other than spermatozoa or on cells from the male or female genital tract, modulating directly or indirectly (via modulation of reactive oxygen species formation) the functional state of the spermatozo...|$|R
50|$|Plasma-Lyte is a crystalloid {{solution}} for intravenous infusion with varying electrolyte formulation depending on market. Generally the solution has a composition that mimics <b>human</b> physiological <b>plasma</b> electrolyte concentrations, osmolality and pH.|$|R
25|$|In 2009, it was {{hypothesized}} that DMT may be an endogenous ligand for the σ1 receptor. The concentration of DMT needed for σ1 activation in vitro (50–100 μM) is similar to the behaviorally active concentration measured in mouse brain of approximately 106 μM This is minimally 4 orders of magnitude higher than the average concentrations measured in rat brain tissue or <b>human</b> <b>plasma</b> under basal conditions (see Endogenous DMT), so σ1 receptors are likely to be activated only under conditions of high local DMT concentrations. If DMT is stored in synaptic vesicles, such concentrations might occur during vesicular release. To illustrate, while the average concentration of serotonin in brain tissue is in the 1.5-4 μM range, the concentration of serotonin in synaptic vesicles was measured at 270 mM. Following vesicular release, the resulting concentration of serotonin in the synaptic cleft, to which serotonin receptors are exposed, is estimated to be about 300 μM. Thus, while in vitro receptor binding affinities, efficacies, and average concentrations in tissue or plasma are useful, they are not likely to predict DMT concentrations in the vesicles or at synaptic or intracellular receptors. Under these conditions, notions of receptor selectivity are moot, and it seems probable that most of the receptors identified as targets for DMT (see above) participate in producing its psychedelic effects.|$|E
2500|$|Antithrombin {{is used as}} {{a protein}} {{therapeutic}} that can be purified from <b>human</b> <b>plasma</b> or produced recombinantly (for example, Atryn, which is produced in the milk of genetically modified goats.) ...|$|E
2500|$|The {{discovery}} of cell-free DNA in the maternal plasma has {{allowed for the}} non-invasive determination of the fetal RHD genotype. [...] In May 2017, the Society for Obstetrics and Gynecology of Canada is now recommending that the optimal management of the D-negative pregnant woman {{is based on the}} prediction of the fetal D-blood group by cell-free DNA in maternal plasma with targeted antenatal anti-D prophylaxis. [...] This provides the optimal care for D-negative pregnant women and has been adopted as the standard approach in a growing number of countries around the world. [...] It is no longer considered appropriate to treat all D-negative pregnant women with <b>human</b> <b>plasma</b> derivatives when there are no benefits to her or to the fetus in a substantial percentage of cases.|$|E
5000|$|... #Caption: Aggregation of thrombocytes (platelets). Platelet-rich <b>human</b> blood <b>plasma</b> (left vial) is a turbid liquid. Upon {{addition}} of ADP, platelets are activated {{and start to}} aggregate, forming white flakes (right vial) ...|$|R
40|$|When {{we think}} about trace {{elements}} and bacterial virulence, iron is usually the first metal that comes up. Zinc, although often forgotten, {{is the second most}} abun-dant trace element, after iron, in <b>humans.</b> <b>Plasma</b> concentrations of zinc range be-tween 12 and 16 µM, and practically all zinc is bound to albumin or other proteins [1]. Zinc is found at low levels on mucosal surfaces; in sputum and bronchoalveo-lar lavage the zinc concentration is about 1 µM. Zinc deficiency is associated with susceptibility to infectious diseases, such as otitis media or those causing diarrhea. Several studies suggest that zinc supplemen...|$|R
40|$|This study {{investigated}} the effects of isotenuifolide and tenuifolide B from the stems of Cinnamomum tenuifolium on adenosine diphosphate (ADP) -induced human platelet aggregation. Treatment of <b>human</b> platelet-rich <b>plasma</b> with isotenuifolide (1 and 2 μg/μL) and tenuifolide B (1, 2 and 4 μg/μL) {{did not have any}} significant effect on human platelet aggregation in vitro, however, treatment of <b>human</b> platelet-rich <b>plasma</b> with isotenuifolide (4 μg/μL) resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans. Isotenuifolide is a new butanolide compound, whose structure was characterized by spectral analyses...|$|R
